Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study (Q51483804)
scientific article published in October 2006
Language:
(P31) (Q13442814)
(P50) (Q60996888)
(P304) 1556-1568
(P433) 10
(P478) 28
(P577) Sunday, October 1, 2006
(P921) (Q3025883)
(Q181600)
(Q269829)
(P1433) (Q15716601)
(P1476) "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study" (language: en)
(P2093) Ronald Brazg
Paula J Andryuk
Kaifeng Lu
Peter Stein
Sitagliptin Study 019 Group
other details
description scientific article published in October 2006

External Links